DIGIT-year tmco
outcomes ftcn
similar qlco
patients podg
assigned inpr
early tmco
surgery hlca
assigned inpr
treatment resa
surgery hlca
needed ftcn
rates qnco
pain fndg
relief fndg
perceived menp
recovery orgf
faster qlco
assigned inpr
early tmco
surgery hlca
additional ftcn
studies lbpr
needed ftcn
test inpr
insulin phsu
treatment resa
reproductive clas
aspects qlco
pcos resa
results fndg
study resa
intake ftcn
DIGIT qnco
DIGIT qnco
DIGIT qnco
g qnco
cinnamon food
day tmco
serum bdsu
glucose bacs
triglyceride bacs
cholesterol bacs
total qlco
cholesterol bacs
people popg
type qnco
DIGIT qnco
diabetes dsyn
suggest idcn
inclusion qlco
cinnamon food
diet food
people popg
type qnco
DIGIT qnco
diabetes dsyn
risk qlco
factors cnce
associated qlco
diabetes dsyn
cardiovascular bdsy
diseases dsyn
DIGIT qnco
trials resa
patients podg
n inpr
DIGIT qnco
carvedilol orch
reduced qlco
all-cause cnce
mortality qnco
DIGIT qnco
fixed-effects qlco
model inpr
risk qlco
ratio inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
confidence menp
interval inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
random-effects qlco
model inpr
risk qlco
ratio inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
confidence menp
interval inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
reduction topp
non-fatal fndg
risk qlco
ratio inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
confidence menp
interval inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
evidence ftcn
suggests idcn
bupropion orch
less qlco
effective qlco
varenicline orch
research resa
needed ftcn
confirm qlco
finding fndg
systematic ftcn
review idcn
meta-analysis resa
performed ftcn
randomized resa
controlled ftcn
direct-comparison acty
trials resa
included gngm
adults aggp
receiving qlco
atenolol orch
bisoprolol orch
metoprolol orch
nebivolol orch
carvedilol orch
evaluate ftcn
effects qlco
carvedilol orch
compared acty
mortality qnco
cardiovascular bdsy
events clas
hospital qlco
setting qnco
systolic tmco
hf gngm
histologic ftcn
findings inpr
severe qlco
gastric qlco
atrophy patf
corpus-predominant bpoc
gastritis dsyn
intestinal bpoc
metaplasia comd
increased ftcn
risk qlco
unfavorable qlco
score qnco
high inpr
rate qnco
complications patf
failed ftcn
trials resa
labor ocac
help idcn
counseling fndg
patients podg
considering idcn
trial resa
labor ocac
atypical fndg
antipsychotic phsu
drugs hlca
associated qlco
small qnco
increased ftcn
risk qlco
death fndg
compared acty
placebo resa
hpv virs
vaccine inpr
prevents ftcn
infection dsyn
hpv-DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
development ftcn
related fndg
external spco
genital bdsu
lesions fndg
males popg
DIGIT qnco
DIGIT qnco
years tmco
age orga
administration topp
three qnco
local spco
cortivazol phsu
injections ftcn
followed tmco
suppression menp
axis spco
DIGIT qnco
days tmco
epidural topp
injection ftcn
recovered qlco
rapidly qlco
intra-articular spco
injection ftcn
use inpr
cinnamon food
showed inpr
effect qlco
glycaemic carb
control qlco
short qnco
term inpr
DIGIT qnco
months tmco
effects qlco
use inpr
cinnamon food
glycaemic carb
control qlco
looks orga
promising idcn
one qnco
week tmco
continuous idcn
auricular bpoc
acupuncture topp
decreases qnco
pain fndg
disability fndg
experienced menp
women popg
pregnancy-related dsyn
low idcn
back blor
posterior spco
pelvic bsoj
pain fndg
colchicine orch
prophylaxis topp
initiation ftcn
allopurinol orch
chronic tmco
gouty dsyn
arthritis dsyn
frequency qnco
severity inpr
acute tmco
flares fndg
likelihood qnco
recurrent tmco
flares fndg
small qnco
sample cnce
size spco
short qnco
term inpr
study resa
long-term tmco
studies lbpr
needed ftcn
efficacy resa
p clna
balance fndg
training qlco
used fndg
acute tmco
ankle blor
sprain inpo
effort orgf
future tmco
ankle blor
sprains inpo
current npop
evidence ftcn
insufficient qlco
assess acty
effect qlco
patients podg
chronic tmco
ankle blor
instability fndg
long-term tmco
mortality qnco
follow-up hlca
showed inpr
patients podg
dyslipidemia dsyn
benefited qnco
beginning tmco
treatment resa
gemfibrozil lipd
early tmco
dyslipidemia dsyn
factors cnce
related fndg
metabolic clna
syndrome dsyn
oral spco
contraceptive ftcn
use inpr
high inpr
blood bdsu
pressure ftcn
smoking phpr
exert orgf
greater qnco
effect qlco
risk qlco
ischaemic ftcn
stroke dsyn
associated qlco
migraine dsyn
evidence ftcn
syntax idcn
difficulties fndg
mixed fndg
need ftcn
research resa
investigate ftcn
intervention topp
language lang
difficulties fndg
future tmco
studies lbpr
address spco
limitations ftcn
current npop
evidence ftcn
needed ftcn
definitive tmco
made ftcn
effect qlco
chromium elii
supplementation topp
combined qlco
therapy fndg
tfgs aapp
sulfonylureas orch
hypoglycemic phsu
drug phsu
lower acty
blood bdsu
glucose bacs
level phsu
clinical qlco
symptoms sosy
treatment resa
therapy fndg
early tmco
result fndg
objective qlco
improvement cnce
breastfeeding fndg
associated qlco
improved inpr
self-efficacy menp
percentage idcn
oxalate orch
water inch
soluble qlco
markedly qlco
cinnamon food
DIGIT qnco
turmeric plnt
DIGIT qnco
appeared qlco
primary topp
cause cnce
greater qnco
urinary qlco
oxalate orch
excretion rnlw
oxalate orch
absorption phpr
turmeric plnt
consumption phsf
supplemental ftcn
doses qnco
turmeric plnt
cinnamon food
increase ftcn
urinary qlco
oxalate orch
levels qlco
increasing ftcn
risk qlco
kidney tisu
stone bdsu
formation ftcn
susceptible lbtr
individuals humn
findings inpr
patients podg
benefit qnco
early tmco
continued idcn
lowering acty
cholesterol bacs
levels qlco
current npop
target diap
levels qlco
need ftcn
research resa
performed ftcn
large qnco
sample cnce
sizes spco
well-designed inpr
assess acty
clinical qlco
outcomes ftcn
according socb
preliminary tmco
clinical qlco
evidence ftcn
administration topp
acids chem
study resa
patients podg
clinicians prog
need ftcn
large qnco
randomized resa
trials resa
men popg
risk qlco
cardiovascular bdsy
disease dsyn
better qlco
inform idcn
safety resa
long-term tmco
testosterone horm
use inpr
high inpr
levels qlco
parental famg
smoking phpr
home cnce
associated qlco
reduction topp
health idcn
care acty
contacts idcn
asthma ftcn
several qnco
individual humn
clinical qlco
features qlco
found qnco
associated qlco
significant qlco
intracranial blor
abnormality fndg
patients podg
features qlco
neuroimaging diap
clonidine orch
ssris phsu
snris phsu
gabapentin orch
relaxation acty
therapy fndg
showed inpr
mild qlco
moderate qlco
effect qlco
reducing qlco
hot npop
flushes sosy
women popg
history fndg
breast bpoc
cancer neop
ulcer patf
area spco
larger qnco
DIGIT qnco
positive qlco
probe-to-bone bdsy
test inpr
result fndg
erythrocyte cell
sedimentation npop
rate qnco
DIGIT qnco
h qnco
abnormal inpr
radiograph inpr
result fndg
helpful idcn
diagnosing fndg
presence topp
lower acty
extremity bpoc
osteomyelitis dsyn
patients podg
diabetes dsyn
single-dose clna
famciclovir orch
reduced qlco
time tmco
healing ftcn
herpes dsyn
lesions fndg
approximately qlco
DIGIT qnco
days tmco
compared acty
placebo resa
study resa
essential qlco
acids chem
independent fndg
adjuvant ftcn
therapy fndg
adult humn
depression ftcn
indicated fndg
including ftcn
investigation idcn
dose-response menp
populations popg
findings inpr
together qlco
persistently idcn
low idcn
lung bpoc
function inpr
suggest idcn
outcomes ftcn
adult humn
asthma ftcn
early tmco
childhood tmco
results fndg
suggest idcn
medical ftcn
therapy fndg
using ftcn
alpha-antagonists chvf
calcium phsu
channel cnce
augments qnco
stone bdsu
expulsion fndg
rate qnco
compared acty
standard inpr
therapy fndg
moderately qlco
sized spco
distal spco
ureteral ftcn
stones bdsu
losartan orch
treadmill dora
exercise topp
time tmco
increased ftcn
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
seconds tmco
p clna
DIGIT qnco
DIGIT qnco
quality qlco
life idcn
improved inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
change qnco
oxygen elii
consumption phsf
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
ml qnco
min tmco
p clna
DIGIT qnco
DIGIT qnco
clinical qlco
recommendations idcn
recommendation idcn
DIGIT qnco
nsaids phsu
considered idcn
treatment resa
chronic tmco
strength qlco
strong qlco
adolescent aggp
outcome ftcn
cohort popg
found qnco
disturbances qlco
dependent ftcn
adhd mobd
symptoms sosy
two qnco
patients podg
reported hlca
partial idcn
DIGIT qnco
patients podg
complete food
relieve ftcn
motor mnob
restlessness sosy
receiving qlco
pergolide orch
increasing ftcn
use inpr
opioids hops
patients podg
cancer neop
research resa
improving qlco
quality-of-life idcn
outcomes ftcn
activity fndg
animals anim
exhibits inpr
pattern spco
exogenous ftcn
melatonin horm
rate qnco
spontaneous ftcn
passage spco
ureteral ftcn
stones bdsu
stone bdsu
size spco
location blor
ct gngm
trial resa
effect qlco
daily tmco
DIGIT qnco
mg elii
oral spco
dhea horm
fatigue sosy
well-being fndg
dhea horm
treatment resa
recommended idcn
female qlco
patients podg
sle dsyn
women popg
cholecystectomy topp
leads topp
perception menp
less qlco
constipation fndg
slightly idcn
frequent tmco
defecations orgf
short qnco
term inpr
show inpr
consistent idcn
change qnco
bowel bpoc
function inpr
meta-analyzed resa
newer tmco
research resa
results fndg
separated ftcn
women popg
according socb
menopausal phsf
status qlco
soy aapp
isoflavone-breast bpoc
cancer neop
association socb
real inpr
immediate tmco
improvement cnce
breastfeeding fndg
mother famg
sustained ftcn
appear qlco
due idcn
placebo resa
effect qlco
drugs hlca
used fndg
treat ftcn
pcos resa
appear qlco
associated qlco
low idcn
risk qlco
severe qlco
effects qlco
data medd
populations popg
significant qlco
associations menp
exist cnce
dietary ftcn
patterns spco
identified ftcn
factor cnce
analysis ftcn
metabolic clna
syndrome dsyn
insulin phsu
resistance phsf
evidence ftcn
routine qlco
prescription inpr
inhibitor qlco
patients podg
diastolic clna
hf gngm
inconsistent qlco
increasing ftcn
levels qlco
pharmacologic ftcn
acid lbpr
suppression menp
associated qlco
increased ftcn
risks qlco
nosocomial inpr
infection dsyn
blood bdsu
pressure ftcn
reduction topp
combining mnob
drugs hlca
DIGIT qnco
different qlco
classes clas
approximately qlco
DIGIT qnco
times qnco
greater qnco
doubling acty
dose clna
DIGIT qnco
drug phsu
evidence ftcn
favorable qlco
effectiveness qlco
compared acty
placebo resa
similar qlco
effectiveness qlco
compared acty
nsaids phsu
significant qlco
side spco
effects qlco
including ftcn
decreasing qlco
effectiveness qlco
related fndg
habituation inbe
used fndg
long-term tmco
fasting inpr
DIGIT-hour qnco
postprandial tmco
plasma bdsu
glucose bacs
glycated phsu
hemoglobin aapp
hba gngm
body anst
mass qnco
index qnco
evaluated ftcn
baseline qnco
DIGIT qnco
days tmco
insufficient qlco
evidence ftcn
support cnce
use inpr
herbal qlco
medicines phsu
hiv-infected ftcn
individuals humn
aids dsyn
patients podg
use inpr
local spco
oestrogen phsu
conjunction idcn
pelvic bsoj
floor geoa
muscle tisu
training qlco
surgery hlca
incidence ftcn
post-operative fndg
cystitis fndg
four qnco
weeks tmco
surgery hlca
based idcn
findings inpr
prior evnt
studies lbpr
once-daily tmco
aza orch
DIGIT qnco
gel sbst
effective qlco
option idcn
treatment resa
mild-to-moderate qlco
rosacea euka
febuxostat orch
daily tmco
dose clna
DIGIT qnco
mg elii
DIGIT qnco
mg elii
effective qlco
allopurinol orch
used fndg
fixed bdsu
daily tmco
dose clna
DIGIT qnco
mg elii
lowering acty
serum bdsu
urate bacs
administration topp
fluoroquinolones orch
risk qlco
factor cnce
quebec geoa
epidemic phpr
caused cnce
strain menp
decreases qnco
elements elii
measurable ftcn
physiologic ftcn
pain fndg
response menp
neonate tmco
circumcision topp
predictive qlco
nomogram inpr
six qnco
variables qlco
easily qlco
first qlco
prenatal tmco
visit inpr
allows socb
determination lbpr
patient-specific inpr
chance qlco
successful qlco
vbac topp
women popg
trial resa
labor ocac
well-designed inpr
studies lbpr
testing inpr
promising idcn
strategies menp
consensus socb
outcome ftcn
fatigue sosy
measures ftcn
needed ftcn
conclusion idcn
results fndg
support cnce
use inpr
niacin lbpr
patients podg
ms gngm
doses qnco
studied resa
febuxostat orch
lowered acty
maintained ftcn
serum bdsu
urate bacs
levels qlco
DIGIT qnco
DIGIT qnco
mg elii
dl qnco
allopurinol orch
DIGIT qnco
DIGIT qnco
mg elii
placebo resa
subjects ftcn
hyperuricemia dsyn
gout dsyn
including ftcn
mild qlco
moderately qlco
impaired patf
renal bpoc
function inpr
patient podg
characteristics qlco
obesity fndg
uterine bpoc
size spco
abdominal blor
scars patf
limit cnce
accurate qlco
palpation diap
adnexa bpoc
supplementation topp
vitamin orch
well mnob
daily tmco
weekly tmco
monthly tmco
frequencies tmco
data medd
extraction lbpr
analyses ftcn
quality qlco
assessment acty
conducted inbe
according socb
standards qlco
estrogen phsu
replacement idcn
therapy fndg
doses qnco
used fndg
control qlco
climacteric phsf
symptoms sosy
alter ftcn
incidence ftcn
intensity qlco
nocturnal tmco
periodic inpr
limb bpoc
movements orgf
hctz orch
exercise topp
time tmco
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
seconds tmco
p clna
DIGIT qnco
DIGIT qnco
quality qlco
life idcn
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
change qnco
oxygen elii
consumption phsf
decreased qlco
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
ml qnco
min tmco
p clna
DIGIT qnco
DIGIT qnco
patients podg
started qlco
in-hospital qlco
continued idcn
long-term tmco
statin orch
therapy fndg
patients podg
chronic tmco
gout dsyn
elevated qlco
serum bdsu
acid lbpr
level phsu
allopurinol orch
intolerance orga
refractoriness ftcn
use inpr
pegloticase aapp
DIGIT qnco
mg elii
DIGIT qnco
weeks tmco
DIGIT qnco
weeks tmco
DIGIT qnco
months tmco
resulted fndg
lower acty
acid lbpr
levels qlco
compared acty
placebo resa
bioflavonoids orch
early tmco
outcomes ftcn
renal bpoc
transplantation ftcn
possibly qlco
ho-DIGIT qnco
induction topp
systematic ftcn
review idcn
aims inpr
evaluate ftcn
benefit qnco
side spco
effect qlco
xuezhikang bacs
coronary bpoc
heart bpoc
disease dsyn
chd aapp
complicated ftcn
dyslipidemia dsyn
recommendation idcn
DIGIT qnco
opioids hops
considered idcn
treatment resa
chronic tmco
possible qlco
strength qlco
weak qlco
two qnco
treatments topp
applied hlca
similar qlco
effectiveness qlco
relieved qlco
pain fndg
reduced qlco
size spco
recurrent tmco
ulcers patf
findings inpr
adhd mobd
associated qlco
significant qlco
educational inpr
occupational ftcn
relative qnco
expected idcn
basis phsu
potential qlco
results fndg
support cnce
relationship inpr
childhood tmco
adhd mobd
adult humn
mood clna
anxiety mobd
disorders dsyn
randomized resa
clinical qlco
trials resa
xuezhikang bacs
treatment resa
chd aapp
combined qlco
dyslipidemia dsyn
considered idcn
inclusion qlco
present idcn
study resa
suggests idcn
childhood tmco
adhd mobd
specific inpr
continues idcn
affect menp
functional cnce
domains inpr
unrelated qlco
current npop
psychiatric ftcn
diagnosis resa
contrast qlco
mounting fndg
evidence ftcn
low idcn
serum bdsu
associated qlco
greater qnco
prostate bpoc
cancer neop
risk qlco
features qlco
prostate bpoc
cancer neop
moderate qlco
reduction topp
caffeine orch
intake ftcn
second qlco
half qnco
pregnancy clna
effect qlco
birth inpr
weight idcn
length resa
gestation orgf
pharmacotherapy topp
appears qlco
short qnco
term inpr
long-term tmco
safety resa
established qlco
smokers fndg
lung bpoc
age orga
likelihood qnco
quitting idcn
smoking phpr
mechanism mnob
intervention topp
effect qlco
pooled ftcn
analysis ftcn
data medd
DIGIT qnco
statin orch
trials resa
intensive-dose clna
statin orch
therapy fndg
associated qlco
increased ftcn
risk qlco
new-onset fndg
diabetes dsyn
compared acty
moderate-dose clna
statin orch
therapy fndg
results fndg
small qnco
proportion qnco
children famg
severe qlco
alopecia fndg
obtain acty
persistent tmco
benefit qnco
topical spco
immunotherapy topp
bimanual ftcn
pelvic bsoj
marked qlco
limitations ftcn
evaluating ftcn
adnexa bpoc
ideal qlco
best qlco
knowledge inpr
first qlco
clinical qlco
trial resa
supports cnce
indication ftcn
saffron orch
main qlco
overall qlco
finding fndg
study resa
saffron orch
therapeutic ftcn
benefit qnco
treatment resa
mild qlco
moderate qlco
depression ftcn
older tmco
age orga
lower acty
tobacco plnt
exposure clna
lower acty
lung bpoc
function inpr
predictors idcn
success socb
quitting idcn
smoking phpr
careful acty
preoperative tmco
evaluation hlca
patient podg
selection genf
resection topp
symptomatic ftcn
interdigital spco
neuroma neop
dorsal spco
approach spco
result fndg
high inpr
percentage idcn
successful qlco
results fndg
five qnco
years tmco
following tmco
procedure inpr
xuezhikang bacs
showed inpr
comprehensive qlco
lipid-regulating lipd
effect qlco
effective qlco
reducing qlco
cardiovascular bdsy
events clas
chd aapp
patients podg
complicated ftcn
dyslipidemia dsyn
likely idcn
inclusion qlco
subgroup clas
factors cnce
future tmco
provide acty
information idcn
needed ftcn
strength qlco
specificity qnco
future tmco
clinical qlco
recommendations idcn
concluded bodm
management ocdi
rosacea euka
basic ftcn
skin bdsy
care acty
regimens inpr
including ftcn
daily tmco
use inpr
therapeutic ftcn
optimal qlco
benefits qnco
majority socb
patients podg
elevated qlco
blood bdsu
pressures fndg
controlled ftcn
improved inpr
inhibitor qlco
therapy fndg
prescribed hlca
discharge bdsu
DIGIT qnco
n inpr
DIGIT qnco
DIGIT qnco
included gngm
patients podg
associated qlco
DIGIT qnco
relative qnco
decrease qnco
risk qlco
DIGIT-year tmco
mortality qnco
hazard qlco
ratio inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
confidence menp
interval inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
early tmco
administration topp
oral spco
steroid strd
medication ftcn
patients podg
acute tmco
sciatica sosy
significant qlco
effect qlco
parameters fndg
studied resa
shown inpr
omega-DIGIT qnco
acid lbpr
supplementation topp
provides acty
benefit qnco
heart bpoc
disease dsyn
sudden qlco
cardiac spco
death fndg
due idcn
lack qlco
awareness menp
asthma ftcn
symptoms sosy
heavy qlco
smokers fndg
reluctance menp
visit inpr
selected acty
patients podg
surgery hlca
promotes acty
large qnco
amounts qnco
weight idcn
loss qnco
rare gngm
sometimes tmco
severe qlco
complications patf
additional ftcn
studies lbpr
needed ftcn
efficacy resa
intervention topp
practice inpr
settings qnco
assessed acty
long-term tmco
prognosis hlca
patients podg
according socb
prescription inpr
inhibitor qlco
discharge bdsu
prediction idcn
success socb
time tmco
admission hlca
highly qlco
dependent ftcn
initial ftcn
cervical spco
fatigue sosy
variable qlco
personal orga
experience menp
range inpr
behavioural idcn
interventions clas
required ftcn
study resa
independent fndg
adjuvant ftcn
therapy fndg
major qlco
depression ftcn
adults aggp
indicated fndg
findings inpr
treated ftcn
great qnco
evidence ftcn
low idcn
low idcn
quality qlco
studies lbpr
comparing acty
acupuncture topp
treatment resa
ht dsyn
controlled ftcn
sham orch
acupuncture topp
placebo resa
ht dsyn
five-year tmco
relative qnco
survival ftcn
observed ftcn
expected idcn
survival ftcn
inhibitor qlco
group popg
better qlco
inhibitor qlco
group popg
DIGIT qnco
DIGIT qnco
stable inpr
patients podg
statin orch
therapy fndg
provides acty
long-term tmco
reduction topp
clinical qlco
events clas
compared acty
standard inpr
therapy fndg
current npop
evidence ftcn
favour orch
maintenance acty
low idcn
dose clna
inhaled orgf
corticosteroids horm
prevention qlco
management ocdi
episodic qlco
mild qlco
viral ftcn
induced ftcn
wheeze sosy
group popg
prescription inpr
inhibitor qlco
associated qlco
significant qlco
decrease qnco
risk qlco
DIGIT-year tmco
mortality qnco
hazard qlco
ratio inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
confidence menp
interval inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
low idcn
impact gngm
aerobic qlco
exercise topp
increasing ftcn
intensity qlco
duration phsu
frequency qnco
effective qlco
strategy menp
reducing qlco
fatigue sosy
adults aggp
chronic tmco
auto-immune ftcn
conditions cnce
data medd
shown inpr
budesonide phsu
inhaled orgf
DIGIT qnco
months tmco
cause cnce
significant qlco
improvement cnce
bhr geoa
adolescents aggp
long-term tmco
asthma ftcn
remission neop
agent inpr
clopidogrel orch
effects qlco
patients podg
acute tmco
coronary bpoc
syndromes fndg
st-segment fndg
elevation spco
found qnco
expensive qnco
therapy fndg
less qlco
effective qlco
complete food
cure cnce
DIGIT qnco
toenails bpoc
atypical fndg
antipsychotic phsu
use inpr
associated qlco
increased ftcn
risk qlco
death fndg
compared acty
older tmco
adults aggp
dementia mobd
associated qlco
increased ftcn
risk qlco
stroke dsyn
women popg
medical ftcn
conditions cnce
associated qlco
stroke dsyn
prospective resa
studies lbpr
patients podg
long-term tmco
acid lbpr
suppression menp
needed ftcn
establish qlco
association socb
causal ftcn
disorders dsyn
benefit qnco
acid lbpr
supplementation topp
omega-DIGIT qnco
acids chem
short-term tmco
effects qlco
maternal famg
medications clna
breast-fed orgf
infants aggp
mild qlco
little qnco
risk qlco
infants aggp
higher inpr
dietary ftcn
diversity qlco
associated qlco
lower acty
possibility qlco
metabolic clna
disorders dsyn
women popg
wishing aapp
use inpr
combined qlco
oc gngm
decision menp
unlikely qlco
place acty
higher inpr
risk qlco
cancer neop
use inpr
sensitive idcn
assay lbpr
troponin aapp
early tmco
diagnosis resa
acute tmco
myocardial spco
infarction patf
risk qlco
stratification resa
regardless qlco
time tmco
chest-pain clna
onset qlco
women popg
western spco
countries geoa
pre- mamm
post-menopausal tmco
evidence ftcn
suggest idcn
association socb
intake ftcn
soy aapp
isoflavone orch
breast bpoc
cancer neop
review idcn
shows inpr
overall qlco
positive qlco
effect qlco
speech orgf
language lang
therapy fndg
interventions clas
children famg
phonological ocdi
vocabulary inpr
difficulties fndg
analysis ftcn
relation socb
inhibitor qlco
prescription inpr
mortality qnco
significant qlco
hazard qlco
ratio inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
confidence menp
interval inpr
DIGIT qnco
DIGIT qnco
DIGIT qnco
DIGIT qnco
p clna
DIGIT qnco
DIGIT qnco
risk qlco
maternal famg
infection dsyn
pregnancy clna
predicted qnco
gravida fndg
's clna
occupation ocdi
higher inpr
source idcn
exposure clna
child famg
methylprednisolone horm
injections ftcn
cts gngm
significant qlco
benefits qnco
relieving qlco
symptoms sosy
DIGIT qnco
weeks tmco
reducing qlco
rate qnco
surgery hlca
DIGIT qnco
year tmco
treatment resa
DIGIT qnco
DIGIT qnco
patients podg
surgery hlca
DIGIT qnco
year tmco
uncertain idcn
quality qlco
identified ftcn
trials resa
need ftcn
improved inpr
reporting hlca
study resa
methods ftcn
allocation acty
handling fndg
incomplete idcn
outcome ftcn
data medd
systematic ftcn
review idcn
present idcn
information idcn
relating orch
effectiveness qlco
safety resa
following tmco
interventions clas
analgesics phsu
local spco
carbenoxolone phsu
mouthwash bodm
chlorhexidine orch
similar qlco
agents inpr
corticosteroids horm
topical spco
tetracycline antb
antibiotic antb
mouthwash bodm
methacholine orch
responsiveness ftcn
peak qnco
flow npop
variability cnce
assessed acty
age orga
DIGIT qnco
together qlco
markers clna
atopy gngm
skin bdsy
test inpr
reactivity qlco
allergens clna
three qnco
different qlco
wheezing sosy
phenotypes orga
childhood tmco
transient tmco
early tmco
wheezing sosy
limited inpr
first qlco
three qnco
years tmco
life idcn
unrelated qlco
increased ftcn
airway bpoc
non-atopic patf
wheezing sosy
toddler aggp
early tmco
school mnob
years tmco
associated qlco
positive qlco
peak qnco
flow npop
variability cnce
methacholine orch
ige-associated qlco
wheeze sosy
asthma ftcn
associated qlco
persistent tmco
wheezing sosy
age orga
methacholine orch
peak qnco
flow npop
variability cnce
markers clna
atopy gngm
corticosteroids horm
provide acty
symptomatic ftcn
relief fndg
pain fndg
sore qlco
throat bpoc
addition ftcn
antibiotic antb
therapy fndg
participants popg
severe qlco
exudative ftcn
sore qlco
throat bpoc
whole-grain qnco
intake ftcn
attributed qlco
cereal food
fiber tisu
associated qlco
homa-ir aapp
lower acty
prevalence qnco
metabolic clna
syndrome dsyn
trials resa
interventions clas
improvement cnce
outcome ftcn
measures ftcn
conclusions idcn
limited inpr
using ftcn
score qnco
analysis ftcn
DIGIT qnco
patients podg
receiving qlco
inhibitor qlco
matched qlco
DIGIT qnco
patients podg
receiving qlco
medication ftcn
future tmco
studies lbpr
involving ftcn
subjects ftcn
required ftcn
ssris phsu
trazodone orch
antidepressants lbpr
effective qlco
treatments topp
agitation sosy
psychosis mobd
dementia mobd
risk qlco
infection dsyn
high inpr
susceptible lbtr
pregnant fndg
women popg
epidemics ftcn
associated qlco
level phsu
contact idcn
children famg
low idcn
dose clna
sodium elii
valproate lipd
effective qlco
reducing qlco
broad spco
range inpr
types qlco
behaviours fndg
aggressive tmco
demented mobd
patients podg
arthritis dsyn
ra spco
disease dsyn
entity enty
proven qlco
benefit qnco
nutrition orgf
intervention topp
improvement cnce
symptoms sosy
diminished qnco
antiinflammatory qlco
drug phsu
nsaid phsu
usage ftcn
randomized resa
placebo-controlled resa
clinical qlco
trial resa
lipid-modifying ftcn
agents inpr
men popg
previous tmco
myocardial spco
infarction patf
basis phsu
findings inpr
pain fndg
prevention qlco
recommend idcn
local spco
anesthetic phsu
administered ftcn
advance medd
circumcision topp
procedure inpr
used fndg
contraindicated fndg
recommendation idcn
anesthetic phsu
administered ftcn
newborns aggp
prior evnt
circumcision topp
evidence ftcn
dose-response menp
effect qlco
provides acty
support cnce
causal ftcn
nature ftcn
iatrogenic qlco
acid lbpr
suppression menp
development ftcn
nosocomial inpr
infection dsyn
twice-daily tmco
doxycycline antb
treatment resa
reduced qlco
number qnco
inflammatory ftcn
noninflammatory fndg
lesions fndg
patients podg
moderate qlco
facial spco
acne dsyn
well mnob
antimicrobial phsu
effect qlco
skin bdsy
result fndg
increase ftcn
number qnco
severity inpr
resistant lbtr
organisms orgm
study resa
designed inpr
evaluate ftcn
effects qlco
antioxidant phsu
flavonoid orch
silymarin orch
improving qlco
long-term tmco
postprandial tmco
glycemic carb
weight idcn
control qlco
type qnco
DIGIT qnco
diabetic fndg
patients podg
treated ftcn
glibenclamide orch
curcumin irda
six qnco
human humn
trials resa
anti-inflammatory qlco
activity fndg
combination phob
curcumin irda
quercetin orch
appears qlco
number qnco
size spco
ileal bpoc
rectal spco
adenomas neop
patients podg
toxicity inpo
reduction topp
posterior spco
pelvic bsoj
pain fndg
non-elastic ftcn
pelvic bsoj
support cnce
experienced menp
DIGIT qnco
women popg
posterior spco
pelvic bsoj
pain fndg
analysis ftcn
suggests idcn
reduction topp
risk qlco
inhibitors chvf
component cnce
survival ftcn
benefit qnco
lowered acty
total qlco
cholesterol bacs
tc gngm
triglyceride bacs
tg lbpr
low-density qnco
lipoprotein-cholesterol aapp
compared acty
placebo resa
inositol carb
nicotinate orch
group popg
similar qlco
statins orch
group popg
episodic qlco
high inpr
dose clna
inhaled orgf
corticosteroids horm
provide acty
effective qlco
strategy menp
treatment resa
mild qlco
episodic qlco
viral ftcn
wheeze sosy
childhood tmco
findings inpr
strong qlco
justify ftcn
interventional resa
studies lbpr
focused ftcn
alternative cnce
targets diap
androgenic phsu
treatment resa
carrying acty
clinical qlco
cardiovascular bdsy
metabolic clna
neurological clna
systems medd
suggests idcn
mechanism mnob
bhr geoa
clinical qlco
setting qnco
different qlco
symptomatic ftcn
asthma ftcn
nitrofurantoin orch
transported medd
human humn
milk food
concentrations menp
milk food
serum bdsu
randomized resa
controlled ftcn
trial resa
shown inpr
tongue-ties cgab
affect menp
feeding acty
division acty
successful qlco
improved inpr
feeding acty
mother famg
baby aggp
better qlco
skilled inbe
support cnce
lactation ortf
consultant idcn
bhr geoa
DIGIT qnco
years tmco
age orga
risk qlco
profile ftcn
suggesting idcn
factors cnce
wheezing sosy
symptom sosy
expression topp
predisposing ftcn
patient podg
bhr geoa
higher inpr
maternal famg
caffeine orch
intake ftcn
pregnancy clna
associated qlco
higher inpr
risk qlco
delivering phsu
low idcn
birth inpr
weight idcn
infants aggp
impact gngm
oral spco
steroids strd
outcomes ftcn
suggested idcn
study resa
small qnco
sample cnce
size spco
limited inpr
statistical ocdi
power hcpp
DIGIT qnco
months tmco
exercise topp
systolic tmco
reduced qlco
patients podg
received qlco
losartan orch
DIGIT qnco
DIGIT qnco
hg elii
p clna
DIGIT qnco
DIGIT qnco
hctz orch
DIGIT qnco
DIGIT qnco
hg elii
p clna
DIGIT qnco
DIGIT qnco
behavioral idcn
therapy fndg
resulted fndg
greater qnco
patient podg
satisfaction menp
fewer qnco
incontinence dsyn
symptoms sosy
pessary medd
DIGIT qnco
months tmco
differences qlco
DIGIT qnco
months tmco
conclude bodm
losartan orch
alone grpa
combination phob
hctz orch
well mnob
effective qlco
treatment resa
elevated qlco
systolic tmco
diastolic clna
obese dsyn
patients podg
hypertension fndg
international idcn
cough fndg
guidelines inpr
recommend idcn
trial resa
ics inpr
considered idcn
patients podg
evaluation hlca
including ftcn
chest blor
x-ray diap
consideration fndg
spirometry diap
appropriate qlco
investigations hlca
trial resa
apparently idcn
healthy fndg
persons popg
hyperlipidemia fndg
elevated qlco
high-sensitivity lbpr
c-reactive qlco
protein aapp
levels qlco
rosuvastatin orch
reduced qlco
incidence ftcn
major qlco
cardiovascular bdsy
events clas
large qnco
degree qnco
heterogeneity qlco
results fndg
sources fndg
need ftcn
investigated ftcn
female qlco
diabetic fndg
neurophysiological phsf
confirmation idcn
diagnosis resa
highest qlco
risk qlco
relapse dsyn
risk qlco
death fndg
greater qnco
conventional qlco
antipsychotics phsu
atypical fndg
antipsychotics phsu
minority popg
infants aggp
wheezing sosy
episodes tmco
probably idcn
related fndg
predisposition orga
asthma ftcn
randomized resa
controlled ftcn
trials resa
needed ftcn
future tmco
trials resa
reporting hlca
total qlco
mortality qnco
total qlco
serious qlco
events clas
well mnob
cardiovascular bdsy
renal bpoc
events clas
data medd
similar qlco
previous tmco
study resa
rh clas
suboptimal qlco
medication ftcn
regimen inpr
common inpr
reason idcn
resistance phsf
based idcn
hypothesis idcn
chronic tmco
symptom sosy
heterogeneous qlco
group popg
disorders dsyn
categorization clas
certain qlco
patient podg
specific inpr
subgroups virs
helpful idcn
guiding mnob
future tmco
treatment resa
decision menp
making ftcn
smokers fndg
lung bpoc
function inpr
modify ftcn
habit inbe
result fndg
screening resa
copd dsyn
combined qlco
smoking phpr
cessation acty
advice hlca
statistical ocdi
difference qlco
found qnco
efficacy resa
citalopram orch
risperidone orch
treatment resa
agitation sosy
psychotic fndg
symptoms sosy
patients podg
dementia mobd
study resa
demonstrates acty
used fndg
conjunction idcn
pacifier mnob
dipped gngm
DIGIT qnco
sucrose carb
comfortable fndg
padded anst
physiologic ftcn
restraint medd
useful inpr
decreasing qlco
distress menp
pain fndg
relief fndg
symptoms sosy
associated qlco
recurrent tmco
stomatitis dsyn
clinical qlco
improvement cnce
two qnco
topical spco
medications clna
affect menp
signs fndg
symptoms sosy
lesions fndg
study resa
confirms qlco
effects qlco
plasma bdsu
glucose bacs
well mnob
cholesterol bacs
levels qlco
patients podg
type qnco
DIGIT qnco
diabetes dsyn
procedure inpr
circumcision topp
associated qlco
less qlco
pain fndg
discomfort sosy
takes hlca
less qlco
time tmco
preferred qlco
compared acty
plastibell medd
present idcn
time tmco
evidence ftcn
randomized resa
trials resa
support cnce
blood bdsu
pressure ftcn
targets diap
lower acty
standard inpr
targets diap
people popg
elevated qlco
blood bdsu
pressure ftcn
diabetes dsyn
effects qlco
multiple qnco
treatment resa
options ftcn
subjective inpr
objective qlco
measures ftcn
hirsutism fndg
displayed ftcn
results fndg
primary topp
funding qnco
source idcn
region spco
research resa
development ftcn
foundation orgt
h?¤ssleholm qnco
hospital qlco
organization prog
cinnamon food
extract sbst
moderate qlco
effect qlco
reducing qlco
fasting inpr
plasma bdsu
glucose bacs
concentrations menp
diabetic fndg
patients podg
poor qlco
glycaemic carb
control qlco
patients podg
reported hlca
greater qnco
relief fndg
symptoms sosy
debacterol orch
kenalog-in-orabase carb
treatment resa
provide acty
evidence ftcn
infants aggp
ankyloglossia cgab
patients podg
treated ftcn
niacin lbpr
n inpr
DIGIT qnco
DIGIT qnco
placebo resa
n inpr
DIGIT qnco
DIGIT qnco
grouped spco
according socb
presence topp
absence anab
ms gngm
baseline qnco
useful inpr
tool mnob
tongue-tied cgab
infants aggp
risk qlco
breast-feeding fndg
problems idcn
using ftcn
randomized resa
double-blind resa
placebo-controlled resa
design inpr
DIGIT qnco
type qnco
DIGIT qnco
diabetic fndg
patients podg
maintained ftcn
DIGIT qnco
mg elii
day tmco
glibenclamide orch
diet food
control qlco
poor qlco
glycemic carb
control qlco
randomized resa
three qnco
groups popg
first qlco
two qnco
groups popg
treated ftcn
DIGIT qnco
mg elii
day tmco
silymarin orch
placebo resa
glibenclamide orch
third qnco
group popg
maintained ftcn
glibenclamide orch
alone grpa
DIGIT qnco
days tmco
children famg
behavioural idcn
emotional fndg
problems idcn
wet qlco
beds mnob
need ftcn
first qlco
treated ftcn
behavioural idcn
emotional fndg
problems idcn
first qlco
time tmco
long-term tmco
efficacy resa
glucose bacs
control qlco
observed ftcn
decrease qnco
hba gngm
limited inpr
available ftcn
evidence ftcn
suggests idcn
folate orch
potential qlco
role cnce
supplement ftcn
treatment resa
depression ftcn
findings inpr
support cnce
use inpr
prescribed hlca
graded fndg
aerobic qlco
exercise topp
management ocdi
patients podg
fatigue sosy
systemic ftcn
lupus dsyn
bedwetting sosy
treated ftcn
dbt gngm
treatments topp
normal qnco
alarm phpr
treatment resa
failed ftcn
alarm phpr
treatment resa
dbt gngm
positive qlco
influence idcn
behavioural idcn
emotional fndg
problems idcn
attention menp
subgroups virs
patients podg
likely idcn
help idcn
guide mnob
treatment resa
likely idcn
help idcn
increase ftcn
clinical qlco
impact gngm
future tmco
research resa
given inpr
anesthesia bmod
condition cnce
clamp ftcn
associated qlco
less qlco
painful sosy
procedure inpr
recommend idcn
infants aggp
given inpr
pacifier mnob
circumcision topp
method lbpr
used fndg
infants aggp
significant qlco
tongue-tie cgab
interfering qlco
breast-feeding fndg
shown inpr
improvement cnce
breast-feeding fndg
following tmco
sports prog
activity fndg
adolescents aggp
young tmco
adults aggp
associated qlco
increased ftcn
risk qlco
males popg
females popg
addition ftcn
psychiatric ftcn
disorders dsyn
schizophrenia mobd
major qlco
disorder dsyn
mdd mobd
shown inpr
positive qlco
results fndg
supplementation topp
used fndg
standard inpr
pharmacotherapy topp
nursery edac
school mnob
teachers prog
highest qlco
occupational ftcn
risk qlco
infections dsyn
result fndg
exposure clna
woman popg
's clna
children famg
outcomes ftcn
reported hlca
date food
shown inpr
positive qlco
trend tmco
using ftcn
spironolactone phsu
women popg
pcos resa
hirsutism fndg
efficacy resa
treating ftcn
syndromes fndg
disorders dsyn
superior spco
placebo resa
standard inpr
antidepressants lbpr
problems idcn
standardization resa
safety resa
concerns idcn
limit cnce
applicability qlco
clinical qlco
practice inpr
pneumococcal imft
conjugate imft
vaccine inpr
introduction mnob
children famg
less qlco
likely idcn
frequent tmco
otitis dsyn
media tisu
pressure-equalizing ftcn
tube medd
insertions hlca
excellent qlco
cure cnce
rates qnco
good qlco
tolerability resa
profile ftcn
terbinafine orch
continue idcn
drug phsu
choice acty
treatment resa
toenail blor
onychomycosis dsyn
number qnco
niddm gngm
patients podg
receiving qlco
multiple qnco
medication ftcn
DIGIT qnco
months tmco
persons popg
prehypertension dsyn
stage qlco
DIGIT qnco
hypertension fndg
sustain orch
multiple qnco
lifestyle socb
modifications qlco
control qlco
blood bdsu
pressure ftcn
risk qlco
chronic tmco
disease dsyn
elevated qlco
troponin aapp
levels qlco
patients podg
acute tmco
pulmonary qlco
embolism fndg
high inpr
risk qlco
short-term tmco
death fndg
outcome ftcn
events clas
half qnco
patients podg
presented idcn
disease dsyn
control qlco
treatment resa
average qnco
approximately qlco
one qnco
year tmco
effect qlco
black qlco
outcomes ftcn
health-related fndg
quality qlco
life idcn
sexuality fndg
bone bdsy
health idcn
night tmco
sweats fndg
cost-effectiveness qnco
investigation idcn
insufficient qlco
evidence ftcn
support cnce
effectiveness qlco
melatonin horm
managing ocac
cognitive ftcn
non-cognitive ftcn
sequelae fndg
dementia mobd
behavioral idcn
risk qlco
factors cnce
smoking phpr
oral spco
contraceptive ftcn
use inpr
markedly qlco
increased ftcn
risk qlco
recent tmco
onset qlco
currently tmco
case cnce
people popg
normal qnco
folate orch
levels qlco
folate orch
deficiency qlco
significant qlco
effect qlco
chromium elii
lipid lipd
glucose bacs
metabolism ftcn
found qnco
people popg
diabetes dsyn
use inpr
corticosteroid phsu
regimens inpr
treating ftcn
patients podg
mild qlco
moderate qlco
croup dsyn
supported cnce
several qnco
aspects qlco
screening resa
studied resa
optimal qlco
methods ftcn
including ftcn
instrument medd
use inpr
age orga
screen medd
interval inpr
useful inpr
daily tmco
ingestion biof
DIGIT qnco
ounces qnco
yogurt food
containing acty
lactobacillus bact
acidophilus phsu
decreased qlco
candidal fngs
infection dsyn
studies lbpr
needed ftcn
clarify acty
risk qlco
stroke dsyn
users humn
susceptible lbtr
basis phsu
age orga
smoking phpr
obesity fndg
hypertension fndg
migraine dsyn
history fndg
antibiotic antb
topical spco
steroid strd
alone grpa
combination phob
effective qlco
treatment resa
acute tmco
sinusitis dsyn
primary topp
care acty
setting qnco
currently tmco
available ftcn
evidence ftcn
supports cnce
inference menp
testosterone horm
use inpr
men popg
associated qlco
cardiovascular bdsy
effects qlco
choice acty
dose clna
frequency qnco
based idcn
approach spco
individual humn
's clna
adherence ftcn
long-term tmco
vitamin orch
supplementation topp
prednisolone phsu
DIGIT qnco
mg elii
kg qnco
low-dose resa
dexamethasone phsu
DIGIT qnco
DIGIT qnco
mg elii
kg qnco
found qnco
efficacy resa
currently tmco
recommended idcn
DIGIT qnco
DIGIT qnco
mg elii
kg qnco
dexamethasone phsu
persons popg
h qnco
pylori bpoc
infection dsyn
dyspepsia sosy
gastric qlco
ulcers patf
gastric qlco
hyperplastic patf
polyps anab
risk qlco
duodenal bpoc
ulcers patf
mode qnco
action acty
melatonin horm
presented idcn
patients podg
increase ftcn
output-amplitude spco
timing cnce
system medd
enhancing acty
rhythmicity tmco
activity fndg
reduction topp
sleep orgf
motor mnob
activity fndg
migraine dsyn
women popg
age orga
increases ftcn
risk qlco
ischaemic ftcn
haemorrhagic qlco
stroke dsyn
trial resa
evidence ftcn
effects qlco
n-DIGIT qnco
pufas bacs
depressed fndg
mood clna
limited inpr
difficult qlco
evaluate ftcn
heterogeneity qlco
patients podg
high inpr
risk qlco
cardiovascular bdsy
events clas
diabetes dsyn
targeting ftcn
systolic tmco
blood bdsu
pressure ftcn
less qlco
DIGIT qnco
hg elii
compared acty
less qlco
DIGIT qnco
hg elii
resulted fndg
lower acty
rates qnco
fatal fndg
major qlco
cardiovascular bdsy
events clas
death fndg
cause cnce
higher inpr
rates qnco
events clas
observed ftcn
intensive-treatment resa
group popg
majority socb
infants aggp
wheezing sosy
transient tmco
conditions cnce
associated qlco
diminished qnco
airway bpoc
function inpr
birth inpr
increased ftcn
risks qlco
asthma ftcn
allergies clna
life idcn
compared acty
pravastatin orch
treatment resa
higher inpr
potency qlco
statins orch
atorvastatin orch
simvastatin orch
associated qlco
increased ftcn
risk qlco
new tmco
onset qlco
diabetes dsyn
procedure inpr
delayed qlco
cord mnob
clamping ftcn
time tmco
least qlco
DIGIT qnco
use inpr
compromise fndg
infant aggp
initial ftcn
post-partum tmco
adaptation biof
phase tmco
findings inpr
need ftcn
replicated ftcn
citalopram orch
antidepressants lbpr
recommended idcn
alternatives cnce
antipsychotics phsu
treatment resa
agitation sosy
psychotic fndg
symptoms sosy
associated qlco
dementia mobd
electron bird
beam phpr
ct gngm
coronary bpoc
calcium phsu
score qnco
events clas
independent fndg
standard inpr
risk qlco
factors cnce
standard inpr
risk qlco
factors cnce
refines ftcn
framingham inpr
risk qlco
stratification resa
dietary ftcn
glycemic carb
index qnco
associated qlco
homa-ir aapp
prevalence qnco
metabolic clna
syndrome dsyn
metformin orch
treatment resa
persons popg
risk qlco
diabetes dsyn
weight idcn
lipid lipd
profiles ftcn
insulin phsu
resistance phsf
new-onset fndg
diabetes dsyn
DIGIT qnco
careful acty
assessment acty
lingual blor
function inpr
followed tmco
indicated fndg
successful qlco
approach spco
facilitation ortf
breastfeeding fndg
presence topp
significant qlco
ankyloglossia cgab
patients podg
recently tmco
acute tmco
coronary bpoc
syndrome dsyn
lipid-lowering acty
statin orch
regimen inpr
provides acty
greater qnco
protection fndg
death fndg
major qlco
cardiovascular bdsy
events clas
standard inpr
regimen inpr
results fndg
suggest idcn
opioid hops
therapy fndg
positive qlco
effect qlco
pain fndg
mood clna
little qnco
effect qlco
activity fndg
sleep orgf
conclusion idcn
use inpr
silymarin orch
glibenclamide orch
glycemic carb
control qlco
targeted ftcn
glibenclamide orch
fasting inpr
effect qlco
related fndg
increased ftcn
insulin phsu
sensitivity qlco
peripheral spco
tissues tisu
results fndg
drug-induced ftcn
suppression menp
phk moft
activity fndg
associated qlco
resolution cnce
activity fndg
assessed acty
clinical qlco
histological ftcn
immunohistochemical lbpr
criteria inpr
support cnce
hypothesis idcn
effective qlco
antipsoriatic phsu
activity fndg
modulation spco
phk moft
activity fndg
simple qlco
smoking phpr
cessation acty
advice hlca
combined qlco
spirometric diap
testing inpr
resulted fndg
good qlco
DIGIT qnco
year tmco
cessation acty
rates qnco
subjects ftcn
airway bpoc
obstruction phpr
children famg
followed tmco
DIGIT qnco
DIGIT qnco
years tmco
provided acty
moderate qlco
amount qnco
protection fndg
ear bpoc
infections dsyn
reducing qlco
frequent tmco
otitis dsyn
media tisu
tube medd
procedures acty
greater qnco
amounts qnco
evidence ftcn
short-term tmco
efficacy resa
moderate qlco
pain fndg
small qnco
function inpr
opioids hops
treat ftcn
compared acty
placebo resa
evidence ftcn
insufficient qlco
show inpr
effectiveness qlco
relaxation acty
techniques ftcn
treatment resa
menopausal phsf
vasomotor ftcn
symptoms sosy
treatment resa
effective qlco
treatment resa
placebo resa
acupuncture topp
superficial spco
needle spco
insertion ftcn
paced qnco
respiration biof
oral spco
dexamethasone phsu
dose clna
DIGIT qnco
DIGIT qnco
mg elii
kg qnco
effective qlco
reducing qlco
return qlco
medical ftcn
care acty
ongoing idcn
croup dsyn
children famg
mild qlco
croup dsyn
blood bdsu
pressure ftcn
reduction topp
combining mnob
drugs hlca
DIGIT qnco
classes clas
predicted qnco
basis phsu
additive sbst
effects qlco
ankyloglossia cgab
common inpr
finding fndg
newborn tmco
population popg
represents acty
significant qlco
proportion qnco
breastfeeding fndg
problems idcn
ibuprofen orch
efficacious resa
acetaminophen phsu
treatment resa
pain fndg
fever fndg
adult humn
pediatric qlco
populations popg
study resa
azithromycin antb
least qlco
effective qlco
doxycycline antb
treatment resa
rosacea euka
red qlco
yeast imft
rice phsu
therapeutic ftcn
lifestyle socb
change qnco
decrease qnco
cholesterol bacs
level phsu
increasing ftcn
pain fndg
levels qlco
treatment resa
option idcn
dyslipidemic dsyn
patients podg
statin orch
therapy fndg
follow inpr
endoscopy hcro
indicated fndg
patient podg
multiple qnco
risk qlco
factors cnce
ulcer patf
formation ftcn
symptoms sosy
recur phpr
consistent idcn
evidence ftcn
anxiolytics phsu
aid gngm
smoking phpr
cessation acty
available ftcn
evidence ftcn
rule qlco
possible qlco
effect qlco
oc gngm
users humn
carrying acty
DIGIT qnco
mutation comd
reduced qlco
risk qlco
ovarian bpoc
cancer neop
proportional qlco
duration phsu
use inpr
infected ftcn
women popg
maximum qnco
possible qlco
risk qlco
congenital qlco
abnormality fndg
due idcn
DIGIT qnco
long qlco
term inpr
development ftcn
normal qnco
conclusion idcn
patients podg
diastolic clna
dysfunction qlco
hypertensive fndg
responses orga
exercise topp
DIGIT qnco
months tmco
losartan orch
hctz orch
blunted qlco
systolic tmco
exercise topp
counseling fndg
pharmacotherapy topp
promote acty
sustained ftcn
weight idcn
loss qnco
improving qlco
clinical qlco
outcomes ftcn
birth inpr
cohort popg
one qnco
four qnco
children famg
wheezing sosy
childhood tmco
adulthood tmco
relapsed tmco
remission neop
habitual tmco
diet food
consumption phsf
test inpr
foods food
decreased qlco
gl gngm
metabolic clna
risk qlco
markers clna
overweight sosy
subjects ftcn
evidence ftcn
suggests idcn
mode qnco
action acty
bupropion orch
nortriptyline orch
independent fndg
antidepressant phsu
effect qlco
similar qlco
efficacy resa
nicotine hops
replacement idcn
conclusion idcn
carvedilol orch
compared acty
atenolol orch
bisoprolol orch
metoprolol orch
nebivolol orch
randomized resa
direct qlco
comparison acty
trials resa
reduced qlco
all-cause cnce
mortality qnco
systolic tmco
hf gngm
patients podg
gtn orch
appears qlco
short-term tmco
benefits qnco
DIGIT qnco
months tmco
treatment resa
lateral spco
DIGIT qnco
years tmco
appear qlco
significant qlco
clinical qlco
benefits qnco
compared acty
patients podg
undertaking ocdi
standard inpr
tendon bpoc
rehabilitation bmod
programme ftcn
alone grpa
plasma bdsu
lipid lipd
levels qlco
associated qlco
increased ftcn
risk qlco
inflammatory ftcn
markers clna
level phsu
c-reactive qlco
protein aapp
significant qlco
prediction idcn
coronary bpoc
heart bpoc
disease dsyn
use inpr
vaccine inpr
reduced qlco
rates qnco
anal spco
intraepithelial spco
neoplasia neop
including ftcn
grade fndg
DIGIT qnco
DIGIT qnco
men popg
sex orga
men popg
head-to-head mnob
clinical qlco
trials resa
needed ftcn
direct qlco
comparison acty
frequency qnco
preliminary tmco
data medd
separate qlco
reports hlca
suggest idcn
possibility qlco
aes resd
less qlco
likely idcn
doxycycline antb
minocycline antb
factors cnce
persistence menp
relapse dsyn
sensitization menp
house mnob
dust sbst
mites euka
airway bpoc
female qlco
sex orga
smoking phpr
early tmco
age orga
onset qlco
early tmco
surgery hlca
rapid qlco
relief fndg
sciatica sosy
care acty
outcomes ftcn
similar qlco
one qnco
year tmco
change qnco
second qlco
year tmco
xuezhikang bacs
showed inpr
significant qlco
benefit qnco
incidence ftcn
all-cause cnce
deaths fndg
chd aapp
deaths fndg
myocardial spco
infarction patf
revascularization topp
compared acty
placebo resa
based idcn
conventional qlco
treatment resa
chd aapp
gps dsyn
counseling fndg
physical fndg
activity fndg
using ftcn
pace qnco
protocol inpr
mediators orch
biometrical ocdi
outcomes ftcn
italian popg
primary topp
care acty
context ftcn
scale mnob
reliable qnco
valid qlco
accurate qlco
measure ftcn
shoulder blor
function inpr
patients podg
ra spco
completed qlco
DIGIT qnco
minutes qnco
evidence ftcn
significant qlco
reduction topp
mortality qnco
men popg
aged popg
DIGIT qnco
DIGIT qnco
years tmco
ultrasound medd
screening resa
ssris phsu
sertraline orch
citalopram orch
associated qlco
reduction topp
symptoms sosy
agitation sosy
compared acty
placebo resa
two qnco
studies lbpr
data medd
available ftcn
addressing spco
issues inpr
including ftcn
effectiveness qlco
screening resa
primary topp
care acty
settings qnco
role cnce
enhanced acty
surveillance hlca
primary topp
care acty
physicians prog
referral hlca
diagnostic ftcn
evaluation hlca
non-speech orgf
language lang
long-term tmco
benefits qnco
interventions clas
effects qlco
screening resa
interventions clas
results fndg
study resa
showed inpr
one qnco
application qnco
silver irda
nitrate inch
decrease qnco
severity inpr
pain fndg
ulceration fndg
shortening topp
healing ftcn
time tmco
temporal tmco
distribution ftcn
plms gngm
well mnob
coupling ftcn
plms gngm
phase tmco
position spco
temperature qnco
curve spco
suggest idcn
involvement ftcn
timing cnce
system medd
pathophysiology qlco
ssris phsu
trazodone orch
appear qlco
well mnob
compared acty
placebo resa
typical qlco
antipsychotics phsu
atypical fndg
antipsychotics phsu
guidance clna
accuracy qlco
joint medd
injection ftcn
allowing socb
rapidly qlco
higher inpr
accuracy qlco
experienced menp
rheumatologists prog
found qnco
exposure clna
nsaids phsu
opioids hops
period tmco
DIGIT-DIGIT qnco
days tmco
humeral bpoc
shaft medd
fracture inpo
associated qlco
known qlco
favorable qlco
results fndg
pennsaid orch
topical spco
nsaid phsu
preparations ftcn
diagnostic ftcn
performance acty
sensitive idcn
cardiac spco
troponin aapp
assays lbpr
excellent qlco
assays lbpr
early tmco
diagnosis resa
acute tmco
myocardial spco
infarction patf
patients podg
recent tmco
onset qlco
chest blor
pain fndg
msm popg
DIGIT qnco
years tmco
age orga
older tmco
history fndg
anal spco
condyloma dsyn
risk qlco
anal spco
condyloma dsyn
development ftcn
evidence ftcn
insufficient qlco
show inpr
exercise topp
effective qlco
treatment resa
vasomotor ftcn
menopausal phsf
symptoms sosy
present idcn
trial resa
evaluated ftcn
tolerability resa
red qlco
yeast imft
rice phsu
pravastatin orch
patients podg
unable fndg
statins orch
myalgia sosy
controlled ftcn
study resa
showed inpr
significant qlco
short-term tmco
efficacy resa
carbamazepine orch
agitation sosy
good qlco
safety resa
tolerability resa
contrast qlco
adulthood tmco
antisocial mobd
drug phsu
disorders dsyn
appeared qlco
part qnco
independent fndg
sustained ftcn
adhd mobd
combination phob
low-dose resa
spironolactone phsu
metformin orch
superior spco
drug phsu
alone grpa
terms inpr
clinical qlco
benefits qnco
compliance acty
women popg
pcos resa
brief tmco
intervention topp
increase ftcn
patients podg
health idcn
care acty
providers prog
behavioral idcn
goals inpr
lead topp
increased ftcn
physical fndg
activity fndg
weight idcn
loss qnco
elevated qlco
troponin aapp
level phsu
acute tmco
stroke dsyn
common inpr
associated qlco
ecg diap
changes qnco
suggestive ftcn
myocardial spco
ischemia dsyn
increased ftcn
risk qlco
death fndg
active ftcn
approach spco
diagnosis resa
management ocdi
precursor idcn
lesions fndg
often tmco
prevent phsu
development ftcn
vulvar bpoc
cancer neop
found qnco
insufficient qlco
evidence ftcn
acupuncture topp
effective qlco
controlling ftcn
menopausal phsf
vasomotor ftcn
symptoms sosy
found qnco
arguments socb
favour orch
smokers fndg
lung bpoc
function inpr
tool mnob
enhancing acty
smoking phpr
cessation acty
given inpr
high inpr
cereal food
fiber tisu
content cnce
lower acty
glycemic carb
index qnco
attributes qlco
whole-grain qnco
foods food
recommendation idcn
increase ftcn
whole-grain qnco
intake ftcn
risk qlco
metabolic clna
syndrome dsyn
large-scale mnob
long-term tmco
controlled ftcn
studies lbpr
therapy fndg
provide acty
definitive tmco
assessment acty
risk qlco
numerous qnco
smaller qnco
clinical qlco
trials resa
well mnob
population-based idcn
longitudinal spco
studies lbpr
fail ftcn
support cnce
historical fndg
idea qlco
therapy fndg
increased ftcn
risk qlco
prostate bpoc
cancer neop
symptoms sosy
due idcn
benign qlco
prostatic spco
hyperplasia patf
childhood tmco
adhd mobd
specific inpr
adult humn
psychiatric ftcn
disorders dsyn
antisocial mobd
drug phsu
abuse fndg
disorders dsyn
risk qlco
considered idcn
context ftcn
medical ftcn
need ftcn
drugs hlca
efficacy resa
evidence ftcn
medical ftcn
comorbidity idcn
efficacy resa
safety resa
alternatives cnce
findings inpr
need ftcn
careful acty
consideration fndg
judging prog
population-based idcn
screening resa
programme ftcn
introduced ftcn
ankyloglossia cgab
plays fndg
significant qlco
role cnce
early tmco
breast-feeding fndg
difficulties fndg
effective qlco
therapy fndg
difficulties fndg
sports prog
cause cnce
enhanced acty
mortality qnco
triggered qlco
athletes prog
affected ftcn
cardiovascular bdsy
conditions cnce
predisposing ftcn
life-threatening fndg
ventricular spco
arrhythmias patf
physical fndg
exercise topp
survivors podg
cancer neop
opioids hops
experienced menp
symptomatic ftcn
hypogonadism dsyn
higher inpr
levels qlco
depression ftcn
fatigue sosy
sexual bhvr
dysfunction qlco
treating ftcn
patients podg
colchicine orch
initiation ftcn
allopurinol orch
therapy fndg
DIGIT qnco
months tmco
supported cnce
data medd
dilute ftcn
alcohol orch
injection ftcn
effective qlco
treatment resa
option idcn
patients podg
's clna
neuroma neop
surgical hlca
procedure inpr
associated qlco
complications patf
ankyloglossia cgab
common inpr
finding fndg
newborn tmco
population popg
affects menp
breastfeeding fndg
selected acty
infants aggp
present idcn
analysis ftcn
provides acty
estimate qnco
average qnco
treatment resa
effects qlco
testosterone horm
therapy fndg
middle-aged aggp
men popg
evidence ftcn
promise idcn
treatment resa
effect qlco
omega-DIGIT qnco
acids chem
depression ftcn
adults aggp
statement idcn
definitive tmco
clinical qlco
efficacy resa
premature tmco
systemic ftcn
lupus dsyn
self-management clna
course tmco
effects qlco
reducing qlco
fatigue sosy
depression ftcn
improving qlco
coping inbe
skills inbe
self-efficacy menp
h qnco
pylori bpoc
infection dsyn
nsaid phsu
use inpr
advanced qlco
age orga
independent fndg
risk qlco
factors cnce
subsequent tmco
ulcer patf
formation ftcn
patients podg
doppler diap
evidence ftcn
diastolic clna
dysfunction qlco
rest moft
hypertensive fndg
response menp
exercise topp
receptor aapp
blockade phsu
hypertensive fndg
response menp
exercise topp
increases ftcn
exercise topp
tolerance qlco
quality qlco
life idcn
subjects ftcn
severe qlco
asthma ftcn
age orga
DIGIT qnco
associated qlco
reduced qlco
expiratory ortf
flow npop
female qlco
parents famg
asthma ftcn
increased ftcn
risk qlco
asthma ftcn
adult humn
overweight sosy
obese dsyn
adolescents aggp
pcos resa
DIGIT qnco
months tmco
treatment resa
rosiglitazone orch
superior spco
drospirenone orch
improving qlco
risk qlco
profile ftcn
effective qlco
inferior socb
attenuating acty
hyperandrogenemia fndg
results fndg
injection ftcn
corticosteroids horm
patients podg
shoulder blor
pain fndg
due idcn
soft dsyn
tissue inpr
disorders dsyn
usg-guidance clna
therapeutic ftcn
effectiveness qlco
effects qlco
patients podg
migraine dsyn
common inpr
reasons idcn
misdiagnosis fndg
include acty
headache sosy
triggers clna
pain fndg
location blor
associated qlco
features qlco
guilt menp
provocation phpr
location blor
association socb
attributed qlco
sinus bsoj
headache sosy
evidence ftcn
insufficient qlco
show inpr
relative qnco
effectiveness qlco
exercise topp
compared acty
ht dsyn
yoga dora
us-guided mnob
arthrocentesis topp
injection ftcn
knee blor
superior spco
anatomic qlco
palpation-guided mnob
arthrocentesis topp
resulting ftcn
less qlco
procedural inpr
pain fndg
improved inpr
arthrocentesis topp
success socb
greater qnco
synovial bpoc
fluid sbst
complete food
joint medd
decompression ftcn
improved inpr
clinical qlco
outcomes ftcn
study resa
negative qlco
study resa
suggestion idcn
benefit qnco
methylprednisolone horm
acetate orch
population popg
young tmco
adults aggp
acute tmco
radicular idcn
low idcn
back blor
pain fndg
since tmco
occurring tmco
compound chem
side-effects ftcn
treatment resa
depression ftcn
founded qnco
soy aapp
isoflavone orch
intake ftcn
lower acty
risk qlco
breast bpoc
cancer neop
pre- mamm
post-menopausal tmco
women popg
asian popg
countries geoa
currently tmco
studies lbpr
antidepressants lbpr
treatment resa
agitation sosy
psychosis mobd
dementia mobd
conclusion idcn
cohort popg
patients podg
prescription inpr
inhibitor qlco
associated qlco
significant qlco
decrease qnco
long-term tmco
mortality qnco
insufficient qlco
scientific ocdi
evidence ftcn
conclude bodm
maternity idcn
support cnce
belts mnob
pregnancy-related dsyn
low idcn
back blor
pain fndg
pelvic bsoj
girdle mnob
pain fndg
ms gngm
defined inpr
basis phsu
meeting hlca
=DIGIT qnco
DIGIT qnco
criteria inpr
current npop
national inpr
cholesterol bacs
education edac
program ftcn
guidelines inpr
small qnco
subgroup clas
patients podg
high-density qnco
lipoprotein aapp
cholesterol bacs
determinations gora
baseline qnco
basis phsu
=DIGIT qnco
DIGIT qnco
criteria inpr
total qlco
population popg
excluding acty
high-density qnco
lipoprotein aapp
cholesterol bacs
criterion inpr
limited inpr
evidence ftcn
controlled ftcn
trials resa
use inpr
oestrogens horm
prevention qlco
management ocdi
pelvic bsoj
organ bpoc
prolapse anab
heterogeneity qlco
study resa
design inpr
needs ftcn
addressed spco
future tmco
research resa
order qlco
test inpr
efficacy resa
intervention topp
present idcn
prospective resa
study resa
included gngm
patients podg
normal qnco
slightly idcn
impaired patf
ejection orga
fraction idcn
=DIGIT qnco
surviving phsu
first qlco
hospitalization hlca
hf gngm
contrast qlco
findings inpr
continued idcn
benefits qnco
long-term tmco
follow-up hlca
described idcn
literature inpr
patients podg
achilles bpoc
tendinopathy dsyn
treated ftcn
gtn orch
analysis ftcn
consistent idcn
prior evnt
reports hlca
showing inpr
inhibitors chvf
decrease qnco
risk qlco
death fndg
following tmco
recent tmco
reducing qlco
cardiovascular bdsy
mortality qnco
compared acty
acupuncture topp
sham orch
acupuncture topp
evidence ftcn
significant qlco
difference qlco
effect qlco
menopausal phsf
vasomotor ftcn
symptoms sosy
inverse qlco
association socb
metabolic clna
syndrome dsyn
features qlco
cross-sectional spco
study resa
addition ftcn
regardless qlco
psychiatric ftcn
status qlco
adhd mobd
placed acty
children famg
relative qnco
risk qlco
educational inpr
vocational ocac
statin orch
therapy fndg
early tmco
leads topp
reduction topp
clinical qlco
events clas
DIGIT qnco
days tmco
consistent idcn
greater qnco
early tmco
effects qlco
exert orgf
anti-inflammatory qlco
activity fndg
inhibition acty
number qnco
different qlco
molecules sbst
play fndg
role cnce
inflammation patf
immediate tmco
improvement cnce
nipple-pain sosy
breastfeeding fndg
scores qnco
placebo resa
effect qlco
nipple bpoc
pain fndg
relevance qlco
clinical qlco
practice inpr
review idcn
provides acty
comprehensive qlco
understanding menp
effectiveness qlco
maternity idcn
support cnce
belts mnob
relief fndg
low idcn
back blor
pain fndg
pregnancy clna
healthcare hlca
professionals prog
providing acty
evidence-based idcn
advice hlca
patients podg
review idcn
found qnco
support cnce
use inpr
systemic ftcn
acyclovir nnon
valacyclovir orch
prevention qlco
treatment resa
exercise topp
systolic tmco
DIGIT qnco
DIGIT qnco
hg elii
mean qnco
DIGIT qnco
patients podg
randomized resa
losartan orch
DIGIT qnco
DIGIT qnco
hg elii
DIGIT qnco
patients podg
received qlco
hctz orch
sonographic diap
needle spco
guidance clna
performance acty
outcomes ftcn
outpatient clas
ia mamm
injections ftcn
significant qlco
findings inpr
treatment resa
prognosis hlca
childhood tmco
asthma ftcn
targeting ftcn
preventive qlco
educational inpr
strategies menp
understanding menp
onset qlco
asthma ftcn
adult humn
life idcn
compared acty
acupuncture topp
treatment resa
appeared qlco
benefit qnco
acupuncture topp
acupuncture topp
appeared qlco
less qlco
effective qlco
ht dsyn
asthmatic dsyn
heredity biof
predisposition orga
early tmco
life idcn
atopy gngm
plus qlco
early tmco
passive qlco
smoke phpr
exposure clna
recurrent tmco
chest blor
infections dsyn
influences idcn
occurrence tmco
wheeze sosy
asthma ftcn
DIGIT qnco
years tmco
age orga
based idcn
significant qlco
rate qnco
side spco
effects qlco
opioids hops
lack qlco
superiority socb
nsaids phsu
opioids hops
recommended idcn
treatment resa
chronic tmco
once-daily tmco
aza orch
DIGIT qnco
gel sbst
well mnob
accepted idcn
patients podg
flexibility qlco
patient podg
well mnob
dermatologist prog
